We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Health Effects Following Use of Lead Free Ammunition Used With HK416

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: November 22, 2011
Last Update Posted: October 16, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Norwegian Defence Research Establishment
Information provided by (Responsible Party):
Svein Grahnstedt, Oslo University Hospital
The purpose of this study is to determine whether use of lead free ammunitions cause more respiratory problems than use of lead containing ammunitions.

Lung Function Tests Markers of Inflammation

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: In Norwegian: Helseffekter av Stoff Som Avgis Ved Skyting Med HK416

Further study details as provided by Svein Grahnstedt, Oslo University Hospital:

Primary Outcome Measures:
  • Forced Expiratory Volume (FEV1) [ Time Frame: Before, Immediately after, and 24 hrs after exposure ]

Secondary Outcome Measures:
  • Inflammation markers [ Time Frame: Before and 24 hrs after esposure ]

Other Outcome Measures:
  • Subjective Symptoms [ Time Frame: During exposure, and during the 24 hrs after exposure ]

Biospecimen Retention:   Samples Without DNA
Sputum and serum

Enrollment: 55
Study Start Date: November 2011
Study Completion Date: March 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Leaded ammunition
Non-leaded ammunition
Modified non-leaded ammunition


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Voluntary army soldiers

Inclusion Criteria:

  • healthy volunteers

Exclusion Criteria:

  • active respiratory disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01477645

Norwegian Defence Research Establishment
Kjeller, Akershus, Norway, N-2007
Sponsors and Collaborators
Oslo University Hospital
Norwegian Defence Research Establishment
Study Director: Kjetil Longva, PhD Norwegian Defence Reasearch Establishment
Principal Investigator: Anne-Katrine Borander, MD Oslo University Hospital
Principal Investigator: Øyvind Albert Voie, PhD Norwegian Research Defence Establishment
Study Director: Johny S Kongerud, MD PhD Oslo University Hospital
Principal Investigator: Liv Ingunn Bjoner Sikkeland, PhD Oslo University Hospital
  More Information

Responsible Party: Svein Grahnstedt, Senior Consultant MD PhD, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT01477645     History of Changes
Other Study ID Numbers: 2011/1335
First Submitted: November 18, 2011
First Posted: November 22, 2011
Last Update Posted: October 16, 2013
Last Verified: October 2013

Additional relevant MeSH terms:
Pathologic Processes